Allianz Asset Management Portfolio holdings
AUM
$74.9B
1-Year Return
18.5%
This Quarter Return
+0.9%
1 Year Return
+18.5%
3 Year Return
+81.04%
5 Year Return
+172.66%
10 Year Return
+376.49%
AUM
$85.3B
AUM Growth
+$3.96B
(+4.9%)
Cap. Flow
-$1.57B
Cap. Flow
% of AUM
-1.84%
Top 10 Holdings %
Top 10 Hldgs %
12.67%
Holding
2,183
New
255
Increased
578
Reduced
858
Closed
287
Top Buys
| 1 |
UBS Group
UBS
|
$348M |
| 2 |
Cummins
CMI
|
$319M |
| 3 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$312M |
| 4 |
AbbVie
ABBV
|
$293M |
| 5 |
Gilead Sciences
GILD
|
$290M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
$376M |
| 2 |
GSK
GSK
|
$357M |
| 3 |
Norfolk Southern
NSC
|
$258M |
| 4 |
GE Aerospace
GE
|
$247M |
| 5 |
Freeport-McMoran
FCX
|
$245M |
Sector Composition
| 1 | Financials | 16.56% |
| 2 | Technology | 14.63% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGN
1676
DELISTED
Aegion Corp
AEGN
| $230K | ﹤0.01% |
12,156
-91,344
| -88% | -$1.73M |
|
|
GM.WS.B
1677
DELISTED
General Motors Company
GM.WS.B
| $230K | ﹤0.01% |
14,352
+4,205
| +41% | +$67.4K |
|
1678
Aecom
ACM
$16.8B
| $229K | ﹤0.01% |
6,825
-37,889
| -85% | -$1.27M |
|
1679
Churchill Downs
CHDN
$7.18B
| $229K | ﹤0.01% |
11,010
-9,540
| -46% | -$198K |
|
|
AAV
1680
DELISTED
Advantage Oil & Gas Ltd
AAV
| $224K | ﹤0.01% |
28,914
-12,617
| -30% | -$97.7K |
|
1681
Molina Healthcare
MOH
$9.47B
| $220K | ﹤0.01% |
+3,125
| New | +$220K |
|
1682
Tidewater
TDW
$2.86B
| $220K | ﹤0.01% |
301
-32
| -10% | -$23.4K |
|
|
S
1683
DELISTED
Sprint Corporation
S
| $220K | ﹤0.01% |
48,416
-75,502
| -61% | -$343K |
|
|
WDR
1684
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $218K | ﹤0.01% |
+4,600
| New | +$218K |
|
1685
Liquidity Services
LQDT
$836M
| $216K | ﹤0.01% |
22,390
-340
| -1% | -$3.28K |
|
|
HSNI
1686
DELISTED
HSN, Inc.
HSNI
| $216K | ﹤0.01% |
3,080
-140
| -4% | -$9.82K |
|
1687
StoneX
SNEX
$5.37B
| $214K | ﹤0.01% |
+14,479
| New | +$214K |
|
1688
TechnipFMC
FTI
$16B
| $213K | ﹤0.01% |
+6,864
| New | +$213K |
|
|
VRN
1689
DELISTED
Veren
VRN
| $212K | ﹤0.01% |
8,362
-51,105
| -86% | -$1.3M |
|
1690
Citizens Financial Group
CFG
$22.3B
| $211K | ﹤0.01% |
+7,735
| New | +$211K |
|
|
INN
1691
Summit Hotel Properties
INN
$614M
| $211K | ﹤0.01% |
+16,205
| New | +$211K |
|
1692
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.42B
| $210K | ﹤0.01% |
+3,212
| New | +$210K |
|
1693
New Jersey Resources
NJR
$4.72B
| $210K | ﹤0.01% |
7,630
-1,930
| -20% | -$53.1K |
|
|
TFCFA
1694
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $208K | ﹤0.01% |
6,341
-21,707
| -77% | -$712K |
|
1695
FTI Consulting
FCN
$5.46B
| $206K | ﹤0.01% |
4,985
-9,450
| -65% | -$391K |
|
1696
Omnicom Group
OMC
$15.4B
| $206K | ﹤0.01% |
2,936
-1,647
| -36% | -$116K |
|
1697
Perrigo
PRGO
$3.12B
| $205K | ﹤0.01% |
1,110
-34,622
| -97% | -$6.39M |
|
1698
John Wiley & Sons Class A
WLY
$2.13B
| $201K | ﹤0.01% |
+3,709
| New | +$201K |
|
1699
Corcept Therapeutics
CORT
$7.31B
| $199K | ﹤0.01% |
+33,035
| New | +$199K |
|
1700
Banc of California
BANC
$2.65B
| $196K | ﹤0.01% |
14,225
| – | – |
|